Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure.

Kamel R, Leroy J, Vandecasteele G, Fischmeister R

DOI: 10.1038/s41569-022-00756-z
Published: 2023 Feb
Container: Nature reviews. Cardiology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41569-022-00756-z,
  title = {Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure.},
  author = {Kamel R and Leroy J and Vandecasteele G and Fischmeister R},
  year = {2023},
  journal = {Nature reviews. Cardiology},
  doi = {10.1038/s41569-022-00756-z},
  url = {https://doi.org/10.1038/s41569-022-00756-z}
}

RIS

TY  - JOUR
TI  - Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure.
AU  - Kamel R
AU  - Leroy J
AU  - Vandecasteele G
AU  - Fischmeister R
PY  - 2023
JO  - Nature reviews. Cardiology
DO  - 10.1038/s41569-022-00756-z
UR  - https://doi.org/10.1038/s41569-022-00756-z
ER  -

APA

R, K., J, L., G, V., & R, F. (2023). Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure.. Nature reviews. Cardiology. https://doi.org/10.1038/s41569-022-00756-z

Source records

pubmed · retrieved 2026-09-26T21:25:25.711Z